联系客服

000028 深市 国药一致


首页 公告 一致B:2021年半年度财务报告(英文版)

一致B:2021年半年度财务报告(英文版)

公告日期:2021-08-17

一致B:2021年半年度财务报告(英文版) PDF查看PDF原文
Section IX Financial Reporting
Report of the Auditors

Consolidated financial statements for the six mo nt hs ended 30 June 2021 haven’t
been audited.


            CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.

                        CONSOLIDATED BALANCE SHEET

                                As at 30 June 2021

                          (Expressed in Renminbi Yuan)

ASSETS                                Note V                        30 June 2021              31 December 2020
Current assets

  Cash and bank balances                1                        5,876,638,427.56                5,998,204,295.87
  Notes receivable                        2                          606,070,192.39                  622,115,477.04
  Accounts recei va ble                    3                      17,761,176,449.25              13,799,971,014.22
  Recei va ble financing                    4                          345,906,887.55                1,404,987,700.38
  Advances to suppliers                    5                          615,602,916.31                  480,313,574.71
  Other receivables                        6                          662,274,841.26                  535,228,747.69
    Incl: Di vidend receivable                                                        -                              -
  Inventories                              7                        7,219,658,618.62                6,285,010,674.46
  Contract Assets                        8                          17,066,105.53                  15,177,731.64
  Other current assets                    9                          101,585,930.05                  121,082,863.45
Total current assets                                                33,205,980,368.52              29,262,092,079.46
Non-current assets

  Long-term equity investments            10                        2,427,605,792.21                2,287,019,627.99
 Other equity instrument investment        11                          99,488,340.28                  99,488,340.28
  Other  non-current    financial        12

  assets                                                            117,974,908.51                  120,972,350.24
  Investment properties                  13                        123,389,130.71                  127,444,379.94
  Fixed assets                          14                        840,386,519.64                  854,191,083.27
  Construction in progress                15                          64,636,735.93                  46,631,190.23
  Right-of-use assets                    16                        2,523,874,174.71                2,356,952,392.99
  Intangible assets                        17                        751,492,524.18                  734,345,179.40
  Goodwill                              18                        2,932,001,316.63                2,747,375,281.11
  Long-term prepaid expenses            19                        523,192,988.98                  457,705,276.09
  Deferred tax assets                    20                          96,595,749.33                  92,118,767.81
  Other non-current assets                21                        484,259,854.32                  408,197,522.84
Total non-current assets                                            10,984,898,035.43              10,332,441,392.19
Total assets                                                        44,190,878,403.95              39,594,533,471.65
The accompanying notes form an integral part of these financialstatements


            CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.

                  CONSOLIDATED BALANCE SHEET (Continued)

                                As at 30 June 2021

                          (Expressed in Renminbi Yuan)

LIABILITIES AND EQUITY                    Note V                    30 June 20 21          31 December 2020
Current liabilities

  Short-term borrowings                        22                  4,632,933,904.39            1,612,187,020.12
  Notes payable                                23                  6,780,425,089.17            7,520,165,274.69
  Accounts payable                            24                  9,642,504,836.50            7,697,451,142.50
  Receipts in advance                          25                      14,868,097.97              12,352,466.64
  Contract liabilities                            26                    316,827,151.78              368,600,357.14
  Employee benefits payable                    27                    242,205,983.09              357,212,047.10
  Tax payable                                  28                    298,201,588.13              316,867,149.16
  Other payables                              29                  1,531,899,017.87            1,599,166,881.14
Non-current liabilities due within one year          30                    798,170,618.10              748,732,059.89
  Other current liabilities                        31                      22,432,447.97     
[点击查看PDF原文]